🇬🇧 Krazati in United Kingdom

Krazati (ADAGRASIB) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Local brand name: Krazati
  • Status: approved

Krazati in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United Kingdom

Frequently asked questions

Is Krazati approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for Krazati in United Kingdom?

Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.